JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (1978) 78, 71-81    DOI: 10.1677/joe.0.0780071
© 1978 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JORDAN, V. C.
Right arrow Articles by PRESTWICH, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JORDAN, V. C.
Right arrow Articles by PRESTWICH, G.

DOSE-RELATED EFFECTS OF NON-STEROIDAL ANTIOESTROGENS AND OESTROGENS ON THE MEASUREMENT OF CYTOPLASMIC OESTROGEN RECEPTORS IN THE RAT AND MOUSE UTERUS

 V. C. JORDAN, LINDA ROWSBY, C. J. DIX and G. PRESTWICH

The dose-related effects of non-steroidal antioestrogens and oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat uterus have been determined. The simultaneous administration of tamoxifen or monohydroxytamoxifen and oestradiol on three consecutive days resulted in dose-dependent decreases in both the wet weight of the uterus and the number of available cytoplasmic oestrogen receptors. The oestrogenic triphenylethylenes ICI 47 699 and ICI 3188 both produced dose-dependent decreases in the number of available cytoplasmic oestrogen receptors. Increasing doses of ICI 47 699 resulted in increasing concentrations of oestrogen receptors within the nucleus. The effects of tamoxifen and oestradiol-17β were compared in the ovariectomized mouse; replenishment of uterine oestrogen receptors was less evident in tamoxifen-treated animals than in animals receiving oestradiol, although increases in uterine weight were similar. A single large dose of tamoxifen (50 µg) produced a prolonged depletion of cytoplasmic oestrogen receptors whilst stimulating rises in uterine weight and DNA and protein content. The results demonstrate that the depletion of the uterine cytoplasmic oestrogen receptor pool is a function of the dose administered for any compound with the ability to translocate oestrogen receptors to the nucleus and as such is not an exclusive characteristic of non-steroidal antioestrogens.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
A Makker, F W Bansode, V M L Srivastava, and M M Singh
Antioxidant defense system during endometrial receptivity in the guinea pig: effect of ormeloxifene, a selective estrogen receptor modulator
J. Endocrinol., January 1, 2006; 188(1): 121 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Jelovac, L. Macedo, V. Handratta, B. J. Long, O. G. Goloubeva, J. N. Ingle, and A. M. H. Brodie
Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model
Clin. Cancer Res., November 1, 2004; 10(21): 7375 - 7381.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Martel, C. Labrie, A. Belanger, S. Gauthier, Y. Merand, X. Li, L. Provencher, B. Candas, and F. Labrie
Comparison of the Effects of the New Orally Active Antiestrogen EM-800 with ICI 182 780 and Toremifene on Estrogen-Sensitive Parameters in the Ovariectomized Mouse
Endocrinology, May 1, 1998; 139(5): 2486 - 2492.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Tremblay, G. B. Tremblay, C. Labrie, F. Labrie, and V. Giguere
EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors {alpha} and {beta}
Endocrinology, January 1, 1998; 139(1): 111 - 118.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the Society for Endocrinology.